Article Details

SPAC Backed by Corvex, Casdin Near Deal for Drug-Price Startup EQRx

Retrieved on: 2021-08-06 09:56:15

Tags for this article:

Click the tags to see associated articles and topics

SPAC Backed by Corvex, Casdin Near Deal for Drug-Price Startup EQRx. View article details on hiswai:

Excerpt

The deal includes a $1.2 billion investment from a subsidiary of SoftBank Group Corp. 9984 -0.16% and Fidelity Investments, among others. This extra ...

Article found on: www.wsj.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up